Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause

被引:67
作者
Knapen, MHJ
Kruseman, ACN
Wouters, RSME
Vermeer, C
机构
[1] Maastricht Univ, Dept Biochem, NL-6200 MD Maastricht, Netherlands
[2] Univ Maastricht, Dept Internal Med, Maastricht, Netherlands
关键词
vitamin K; osteoporosis; bone markers; gamma carboxyglutamate;
D O I
10.1007/s002239900543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum immunoreactive osteocalcin (irOC) consists of two fractions that differ from each other by their affinity for hydroxyapatite. The high and low affinity fractions are referred to as irOC( bound) and irOC(free), respectively. To evaluate whether these fractions are determinants for different characteristics of bone or bone metabolism, we have performed a cross-sectional study among 212 apparently healthy women between 20 and 90 years of age. Bone mineral density (BMD) was determined at the lumbar spine, and the right femur neck, trochanter, and Ward's triangle using dual-energy X-ray absorptiometry (DXA). Biochemical markers for bone formation and resorption were determined in serum and in urine. After classification according to menopausal age, an inverse correlation was found in the 1-10 years postmenopausal women between irOC(free) and BMD, notably of the Ward's triangle and femur neck. It is concluded that in 1-10 years postmenopausal women, irOC(free) is an independent marker for BMD, but that in other age groups the association is less clear or is absent.
引用
收藏
页码:375 / 379
页数:5
相关论文
共 15 条
[1]  
AKESSON K, 1995, J BONE MINER RES, V10, P1823
[2]  
BEHR W, 1986, CLIN CHEM, V32, P1960
[3]  
CAIRNS JR, 1994, J BONE MINER RES, V9, P1989
[4]   EVALUATION OF BONE TURNOVER IN TYPE-I OSTEOPOROSIS USING BIOCHEMICAL MARKERS SPECIFIC FOR BOTH BONE-FORMATION AND BONE-RESORPTION [J].
EASTELL, R ;
ROBINS, SP ;
COLWELL, T ;
ASSIRI, AMA ;
RIGGS, BL ;
RUSSELL, RGG .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (05) :255-260
[5]   CALCIUM-DEPENDENT ALPHA-HELICAL STRUCTURE IN OSTEOCALCIN [J].
HAUSCHKA, PV ;
CARR, SA .
BIOCHEMISTRY, 1982, 21 (10) :2538-2547
[6]   THE EFFECT OF VITAMIN-K SUPPLEMENTATION ON CIRCULATING OSTEOCALCIN (BONE GLA PROTEIN) AND URINARY CALCIUM EXCRETION [J].
KNAPEN, MHJ ;
HAMULYAK, K ;
VERMEER, C .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) :1001-1005
[7]   Osteocalcin detection in aging serum and whole blood: Stability of different osteocalcin fractions [J].
Knapen, MHJ ;
Eisenwiener, HG ;
Vermeer, C .
CLINICA CHIMICA ACTA, 1996, 256 (02) :151-164
[8]   VITAMIN K-INDUCED CHANGES IN MARKERS FOR OSTEOBLAST ACTIVITY AND URINARY CALCIUM LOSS [J].
KNAPEN, MHJ ;
JIE, KSG ;
HAMULYAK, K ;
VERMEER, C .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (02) :81-85
[9]   AN IMPROVED METHOD FOR THE DETERMINATION OF GAMMA-CARBOXYGLUTAMIC ACID IN PROTEINS, BONE, AND URINE [J].
KUWADA, M ;
KATAYAMA, K .
ANALYTICAL BIOCHEMISTRY, 1983, 131 (01) :173-179
[10]  
ORIMO H, 1992, J BONE MINER RES, V7, pS122